Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma
SLC35F6 is upregulated in BC patients compared to normal individuals and is linked to a worse prognosis. SLC35F6 analyzed alongside clinical pathological factors can enhance the accuracy of survival predictions for BLCA patients, suggesting its potential value as a prognostic and predictive biomarker.
Authors
- Wenyu Shi (ORCID: https://orcid.org/0000-0002-2371-3332)
- Siqi Liu (ORCID: https://orcid.org/0000-0001-9744-3681)
- Meng Wu (ORCID: https://orcid.org/0000-0003-2111-2645)
- Jinling Zhang (ORCID: https://orcid.org/0000-0002-6017-7751)
- Yihong Cai
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- Diagnostic Pathology
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1186/s13000-024-01582-2
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Natural Science Foundation of China